Skip to main content
. 2022 Jun 9;11(6):787. doi: 10.3390/antibiotics11060787

Figure 3.

Figure 3

Cytotoxicity of DRS-B2 and different formulations on human HT29 cell line. Means with (*) or (**) are significantly different from control and between them (p < 0.05).